N-acetyl Cysteine to Mitigate Liver Damage in Patients with Deranged Liver Function Undergoing Surgery on Cardiopulmonary Bypass
- PMID: 39365126
- PMCID: PMC11610783
- DOI: 10.4103/aca.aca_156_24
N-acetyl Cysteine to Mitigate Liver Damage in Patients with Deranged Liver Function Undergoing Surgery on Cardiopulmonary Bypass
References
-
- Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947–67. - PubMed
-
- Laribi S, Mebazaa A. Cardiohepatic syndrome: Liver injury in decompensated heart failure. Curr Heart Fail Rep. 2014;11:236–40. - PubMed
-
- Poelzl G, Auer J. Cardiohepatic syndrome. Curr Heart Fail Rep. 2015;12:68–78. - PubMed
-
- Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90:1405–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources